ANA
MIRANDA CASAS
EMÉRITO/A UNIVERSIDAD
Massachusetts General Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Massachusetts General Hospital (8)
2022
-
Polygenic association between attention-deficit/hyperactivity disorder liability and cognitive impairments
Psychological Medicine, Vol. 52, Núm. 14, pp. 3150-3158
2021
-
Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder
Nature Communications, Vol. 12, Núm. 1
2019
-
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
Nature Genetics, Vol. 51, Núm. 1, pp. 63-75
2018
-
A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder
Biological Psychiatry, Vol. 83, Núm. 12, pp. 1044-1053
2017
-
Genetic Overlap Between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence From Genome-wide Association Study Meta-analysis
Biological Psychiatry, Vol. 82, Núm. 9, pp. 634-641
2015
-
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
Nature Neuroscience, Vol. 18, Núm. 2, pp. 199-209
2013
-
Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: Genome-wide association study of both common and rare variants
American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 162, Núm. 5, pp. 419-430
2011
-
Genome-wide association study in German patients with attention deficit/hyperactivity disorder
American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 156, Núm. 8, pp. 888-897